Paul, P., & Azam,Faruque. (2024). Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer. Brac University.
Chicago-viite (17. p.)Paul, Pulock, ja Azam,Faruque. Effect of Performance Status on Efficacy Endpoints in Phase II Trials of Non-small Cell Lung Cancer. Brac University, 2024.
MLA-viite (8. p.)Paul, Pulock, ja Azam,Faruque. Effect of Performance Status on Efficacy Endpoints in Phase II Trials of Non-small Cell Lung Cancer. Brac University, 2024.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.